Atlas Trials

Efficacy and Safety of Anlotinib in Patients With Advanced Gastrointestinal Stromal Tumor After Failure of Imatinib: a Prospective, Single Arm and Multicenter Trial

Clinical trial NCT04106024 · UNKNOWN

Trial details

NCT number
NCT04106024
Sponsor
Cttq
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Gastrointestinal Stromal Tumors
Start date
2018-10-23
Primary completion
2019-10-30
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.